January, 2023

article thumbnail

Immunizing Older Individuals Requires Flexibility, Nuance

Pharmacy Times

When it comes to vaccination efforts, remember that patients 65 years or older are not a homogeneous group.

article thumbnail

How decentralised storage networks can change the game for the pharmaceutical industry

Pharma Phorum

The way pharmaceutical companies manage data carries inherent risks, as exemplified by the constant scandals about data breaches. Is there anything that can be done about this?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Companies Partner Up on Sustainable Pharma Packaging

Pharmaceutical Commerce

Collaboration aims to decrease environmental burden in the space.

article thumbnail

Governing Principles for Successful Biotechnology Companies

PharmExec

Pete O'Heeron, founder, chairman, and CEO of FibroBiologics, explains the key principles that biotechnology companies should follow.

96
article thumbnail

AstraZeneca’s newest asthma launch fills a gap as generics chip away at respiratory flagships

PharmaVoice

A longtime leader in the respiratory space, AstraZeneca has hammered another stake in the ground with its newest asthma treatment, Airsupra

83
article thumbnail

Amazon Pharmacy rolls out service for unlimited generic drug prescriptions for $5 a month

Fierce Healthcare

Amazon Pharmacy rolls out service for unlimited generic drug prescriptions for $5 a month hlandi Mon, 01/23/2023 - 22:15

114
114
article thumbnail

Wearable Device Accurately Tracks Heart Failure Progression

Pharmacy Times

Approximately half of patients with heart failure do not require an implantable monitoring device or do not qualify for thoracic monitoring.

142
142

More Trending

article thumbnail

FDA pulls AZ’s Evusheld for COVID, citing lack of efficacy

Pharma Phorum

AstraZeneca’s revenue boost from COVID-19 therapy Evusheld looks set to be curbed early, as the FDA withdraws authorisation for the antibody on the grounds that it is ineffective against most subvariants now circulating in the US.

article thumbnail

Stars Aligned for Pricing Model? Value-Based Contracts May be Poised for Takeoff

PharmExec

As new forms of cell and gene therapies continue to be developed, life sciences companies and payers need to find alternative ways to pay for these expensive treatments. Value-based contracts, though slow to gain traction so far, may provide the solution these groups are looking for.

91
article thumbnail

Forks in the road lead one medical expert to a ‘game changing’ liver treatment

PharmaVoice

Durect’s chief medical officer altered his retirement plans to take a leading role at the company, which is developing a treatment for severe alcohol-associated hepatitis

91
article thumbnail

The impact of climate change on the pharma supply chain

Pharmaceutical Technology

Pharmaceutical supply chains are extremely vulnerable to the effects of climate change and face many challenges from sourcing to distribution.

Packaging 111
article thumbnail

Study Shows That Breast Milk of Those Vaccinated Against COVID-19 Protects Infants

Pharmacy Times

Antibodies help neutralize the virus, though the levels decrease at the 6-month mark, data indicate.

Vaccines 133
article thumbnail

2023 Fundraising Challenges

NF2 BioSolutions

We are doing 2 fundraising challenges throughout the year this year and you can partake in any whenever you like, get everyone involved from mums, dads, kids, grandparents, aunts, uncles, neighbours, friends and work colleagues. HAVE FUN AND RAISE FUNDS FOR NF2 RESEARCH! CAKE BAKE & COFFEE.

article thumbnail

Can machine learning accelerate drug formulation?

Outsourcing Pharma

Research emerging from the University of Toronto found that using machine learning models was able to guide the design of long-acting drug formulations. Clinical Development

104
104
article thumbnail

Type 1 Diabetes: A Potential Cure

PharmExec

One company pursues a program for a technology they believe is a potential cure for Type 1 diabetes.

87
article thumbnail

Space — the next frontier in drug development

PharmaVoice

Merck, Bristol Myers Squibb and others are taking small R&D steps in space that could lead to giant leaps for patients

87
article thumbnail

Dollar General pilots mobile clinics as it targets a bigger presence in healthcare

Fierce Healthcare

Dollar General pilots mobile clinics as it targets a bigger presence in healthcare hlandi Fri, 01/20/2023 - 18:25

107
107
article thumbnail

FDA Approved IND for CAR T Cell That Target Metastases-Causing Breast Cancer Tumor

Pharmacy Times

The head of the CAR T cell antibody can recognize and target the growth factor in its tumor microenvironment.

FDA 130
article thumbnail

BMS settles lawsuit with two fired employees who refused COVID vaccines

Fierce Pharma

BMS settles lawsuit with two fired employees who refused COVID vaccines kdunleavy Thu, 01/26/2023 - 14:30

Vaccines 100
article thumbnail

Can the FDA keep the momentum going for rare disease drug approvals?

Pharmaceutical Technology

In 2022, the FDA approved only 37 new medicines, an underwhelming number compared to 98 in 2018. However, while only around 34% of the approvals in 2018 were for orphan drugs, 54% new approvals in 2022 were for drugs to treat rare diseases.

Dosage 100
article thumbnail

Cybersecurity Threats & Pharma

PharmExec

The steps companies can take now to better protect themselves and their data.

86
article thumbnail

FDA’s 2022 drug approvals fall short of recent norms

PharmaVoice

The U.S. agency’s lower number of novel drug approvals followed several controversies surrounding a 2021 Alzheimer’s approval

FDA 83
article thumbnail

UnitedHealthcare launches behavioral health coaching program for commercial plans

Fierce Healthcare

UnitedHealthcare launches behavioral health coaching program for commercial plans pminemyer Thu, 01/19/2023 - 15:05

108
108
article thumbnail

Speech Therapy May Effectively Address Long COVID Communication Issues

Pharmacy Times

In addition to the physical symptoms of long COVID, patients have reported vocal, verbal, and cognitive issues that disrupt their ability to communicate.

article thumbnail

JPM23, Day 1: BMS touts new launches as patent cliff looms; Regeneron's Eylea sales disappoint

Fierce Pharma

JPM23, Day 1: BMS touts new launches as patent cliff looms; Regeneron's Eylea sales disappoint. esagonowsky. Mon, 01/09/2023 - 09:55

110
110
article thumbnail

Google and DeepMind share work on medical chatbot Med-PaLM

Pharma Phorum

Google and DeepMind have developed an artificial intelligence-powered chatbot tool called Med-PaLM designed to generate “safe and helpful answers” to questions posed by healthcare professionals and patients.

108
108
article thumbnail

Q&A with Kelly Baker, CFO of Eversana

PharmExec

Baker spoke on topics ranging from pricing, access, the war for talent, and other key areas that are impacting pharma companies.

87
article thumbnail

Nonprofits are bridging R&D’s valley of death

PharmaVoice

How charitable firms such as Advancium are helping to right the market wrongs of drug development

85
article thumbnail

New Jefferson Health program enables clinical, academic nurses to partner on research

Fierce Healthcare

New Jefferson Health program enables clinical, academic nurses to partner on research agliadkovskaya Wed, 01/18/2023 - 14:16

105
105
article thumbnail

Study: Empagliflozin Can Slow Progression of Chronic Kidney Disease to Kidney Failure

Pharmacy Times

Data from a randomized clinical trial supports previous clinical findings on SGLT2 inhibitors and their ability to slow the progression of chronic kidney disease.

127
127
article thumbnail

Moderna now in the crosshairs of Sens. Warren, Welch over price tag for COVID vaccine

Fierce Pharma

Moderna now in the crosshairs of Sens. Warren, Welch over price tag for COVID vaccine kdunleavy Wed, 01/25/2023 - 13:16

article thumbnail

J&J copay lawsuit against drug benefit firm gets green light

Pharma Phorum

Johnson & Johnson has been cleared to continue a lawsuit filed last year against drug benefit programme SaveOnSP, which claims it defrauded a payment assistance programme for patients out of “at least $100 million.”

article thumbnail

Has the Glass Ceiling Finally Been Broken at the Big Four Consulting Firms?

PharmExec

Author Deepa Purushothaman discusses the progress of women and women of color in corporate America.

83
article thumbnail

Woman of the Week: Form Bio’s Claire Aldridge

PharmaVoice

The chief strategy officer of Form Bio is harnessing the new company’s computing power and bioinformatics to spur a genomic revolution

83
article thumbnail

Healthcare ranked lowest for employee satisfaction, Qualtrics survey finds

Fierce Healthcare

Healthcare ranked lowest for employee satisfaction, Qualtrics survey finds aburky Wed, 01/18/2023 - 16:40

105
105
article thumbnail

HSV Offers Promising Target for Preventive, Therapeutic Vaccines

Pharmacy Times

Vaccination provides an opportunity to prevent and treat herpes simplex virus infection.

Vaccines 127
article thumbnail

CDC probes possible safety risk for Pfizer's new COVID shot, sees no need to change vaccine practices

Fierce Pharma

CDC probes possible safety risk for Pfizer's new COVID shot, sees no need to change vaccine practices. zbecker. Tue, 01/17/2023 - 11:49

Vaccines 104